Knight Therapeutics Inc.
TSX:GUD.TO
5.86 (CAD) • At close May 12, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) CAD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||||||
| Current Assets: | ||||||||||||
| Cash & Cash Equivalents
| 80.106 | 58.761 | 71.679 | 85.963 | 229.592 | 169.268 | 244.785 | 496.46 | 514.942 | 237.481 | 283.445 | 0 |
| Short Term Investments
| 92.731 | 95.657 | 119.542 | 77.03 | 181.747 | 261.348 | 459.033 | 291.421 | 272.897 | 257.314 | 143.501 | 0 |
| Cash and Short Term Investments
| 172.837 | 154.418 | 191.221 | 162.993 | 411.339 | 430.616 | 703.818 | 787.881 | 787.839 | 494.795 | 426.946 | 0 |
| Net Receivables
| 113.534 | 98.229 | 94.89 | 67.414 | 82.043 | 125.171 | 2.896 | 8.887 | 32.165 | 16.008 | 0.101 | 0 |
| Inventory
| 102.698 | 91.834 | 92.489 | 72.397 | 56.505 | 70.87 | 1.136 | 1.224 | 0.79 | 1.46 | 0.602 | 0 |
| Other Current Assets
| 7.744 | 20.634 | 22.63 | 4.515 | 4.753 | 85.006 | 17.346 | 1.081 | 30.92 | 17.921 | 2.809 | 0 |
| Total Current Assets
| 396.813 | 365.115 | 395.619 | 307.319 | 554.64 | 698.224 | 717.531 | 799.073 | 799.752 | 499.48 | 428.573 | 0 |
| Non-Current Assets: | ||||||||||||
| Property, Plant & Equipment, Net
| 20.022 | 17.859 | 22.633 | 29.936 | 26.162 | 29.048 | 0.794 | 0.633 | 0.032 | 0.018 | 0.048 | 0 |
| Goodwill
| 86.477 | 79.844 | 82.274 | 75.403 | 77.725 | 88.262 | 0 | 0 | 0 | 0 | -0 | 0 |
| Intangible Assets
| 283.612 | 289.96 | 338.78 | 350.299 | 156.547 | 173.372 | 17.475 | 12.576 | 14.153 | 3.32 | 0.846 | 0 |
| Goodwill and Intangible Assets
| 370.089 | 369.804 | 421.054 | 425.702 | 234.272 | 261.634 | 17.475 | 12.576 | 14.153 | 3.32 | 0.846 | 0 |
| Long Term Investments
| 103.426 | 165.558 | 158.016 | 178.952 | 174.841 | 259.717 | 289.733 | 188.971 | 170.756 | 143.643 | 57.147 | 0 |
| Tax Assets
| 21.247 | 19.39 | 9.31 | 2.048 | 2.432 | 3.991 | 2.959 | 4.73 | 6.077 | 2.527 | -37.243 | 0 |
| Other Non-Current Assets
| 52.2 | 7.767 | 48.204 | 47.934 | 47.329 | 52.689 | 23.34 | 0 | 0 | 0 | 37.243 | 0 |
| Total Non-Current Assets
| 566.984 | 580.378 | 659.217 | 684.572 | 485.036 | 607.079 | 334.301 | 206.91 | 191.018 | 149.508 | 58.041 | 0 |
| Total Assets
| 963.797 | 945.493 | 1,054.836 | 991.891 | 1,039.676 | 1,305.303 | 1,051.832 | 1,005.983 | 990.77 | 648.988 | 486.613 | 0 |
| Liabilities & Equity: | ||||||||||||
| Current Liabilities: | ||||||||||||
| Account Payables
| 78.345 | 85.366 | 106.061 | 65.309 | 44.512 | 72.831 | 0.752 | 0.541 | 0.748 | 0.039 | 0.591 | 0 |
| Short Term Debt
| 20.126 | 19.578 | 20.252 | 28.276 | 53.645 | 52.345 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax Payables
| 0.213 | 1.182 | 2.274 | 7.073 | 13.559 | 18.729 | 10.705 | 7.599 | 5.659 | 4.031 | 4.493 | 0 |
| Deferred Revenue
| 0 | 0 | 0 | 9.728 | 14.612 | 39.855 | 0.183 | 0.282 | 0.355 | 0.293 | 1.04 | 0 |
| Other Current Liabilities
| 12.564 | 7.903 | 12.734 | 4.644 | 2.344 | 206.899 | 5.545 | 5.838 | 2.996 | 2.377 | 2.539 | 0 |
| Total Current Liabilities
| 111.248 | 114.029 | 141.321 | 105.302 | 114.06 | 350.804 | 17.185 | 14.26 | 9.758 | 6.74 | 7.622 | 0 |
| Non-Current Liabilities: | ||||||||||||
| Long Term Debt
| 29.333 | 49.513 | 57.448 | 12.682 | 2.543 | 9.834 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.167 | 0.417 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 3.84 | 2.817 | 4.365 | 12.373 | 21.616 | 27.86 | 0 | 0 | 0 | 0.186 | 0 | 0 |
| Other Non-Current Liabilities
| 24.271 | 32.263 | 25.845 | 19.516 | 15.216 | 1.699 | 4.615 | 0.348 | 0.877 | 0 | 0 | 0 |
| Total Non-Current Liabilities
| 57.444 | 84.593 | 87.658 | 44.571 | 39.375 | 39.393 | 4.615 | 0.515 | 1.294 | 0.186 | 0 | 0 |
| Total Liabilities
| 168.692 | 198.622 | 228.979 | 149.873 | 153.435 | 390.197 | 21.8 | 14.775 | 11.052 | 6.926 | 7.622 | 0 |
| Equity: | ||||||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock
| 534.266 | 540.046 | 599.055 | 628.854 | 694.351 | 723.832 | 761.844 | 761.49 | 760.447 | 439.148 | 341.065 | 0 |
| Retained Earnings
| 154.794 | 150.888 | 161.755 | 191.647 | 174.545 | 52.246 | 232.122 | 195.83 | 178.586 | 160.026 | 125.859 | 0 |
| Accumulated Other Comprehensive Income/Loss
| 80.22 | 29.946 | 41.266 | -0.376 | -1.503 | 17.405 | 20.955 | 20.907 | 30.431 | 35.955 | 9.967 | 0 |
| Other Total Stockholders Equity
| 25.825 | 25.991 | 23.664 | 21.776 | 18.731 | 16.463 | 14.326 | 12.196 | 9.469 | 6.772 | 2.1 | 0 |
| Total Shareholders Equity
| 795.105 | 746.871 | 825.857 | 842.018 | 886.241 | 810.731 | 1,030.032 | 991.208 | 979.718 | 642.062 | 478.991 | 0 |
| Total Equity
| 795.105 | 746.871 | 825.857 | 842.018 | 886.241 | 915.106 | 1,030.032 | 991.208 | 979.718 | 642.062 | 478.991 | 0 |
| Total Liabilities & Shareholders Equity
| 963.797 | 945.493 | 1,054.836 | 991.891 | 1,039.676 | 1,305.303 | 1,051.832 | 1,005.983 | 990.77 | 648.988 | 486.613 | 0 |